SNPHF (Santen Pharmaceutical Co) General and Admin. Expense : $583 Mil (TTM As of Mar. 2025)

View and export this data going back to 2010. Start your Free Trial

What is Santen Pharmaceutical Co General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Santen Pharmaceutical Co's General and Admin. Expense for the three months ended in Mar. 2025 was $156 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2025 was $583 Mil.

Santen Pharmaceutical Co General and Admin. Expense Historical Data

The historical data trend for Santen Pharmaceutical Co's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Santen Pharmaceutical Co General and Admin. Expense Chart

Santen Pharmaceutical Co Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

General and Admin. Expense

Get a 7-Day Free Trial

731.87

712.61

720.14

610.93

590.15

Santen Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
General and Admin. Expense	Get a 7-Day Free Trial															178.75	135.43	145.75	146.20	156.08

Santen Pharmaceutical Co General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $583 Mil.

Santen Pharmaceutical Co General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of Santen Pharmaceutical Co's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Santen Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Santen Pharmaceutical Co Ltd (OTCPK:SNPHF) » Definitions » General and Admin. Expense

Comparable Companies

Traded in Other Exchanges

SNPHY:USA 4536:Japan SZD:Germany

Address

Grand Front Osaka Tower A, 4-20 Ofuka-cho, Kita-ku, Osaka, JPN, 530-8552

Website

http://www.santen.co.jp

Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company reports two primary operating segments: prescription ophthalmic pharmaceuticals and other. The pharmaceuticals segment includes over-the-counter pharmaceuticals, while the other segment includes medical devices. The vast majority of Santen's revenue is derived from its prescription ophthalmic pharmaceuticals segment, which manufactures and distributes prescription and OTC pharmaceuticals. Most of Santen's sales are generated in Japan, followed by other Asian countries.